Quantification of 1,N6-Etheno-2′-deoxyadenosine in human urine by column-switching LC/APCI-MS/MS

1,N6-Etheno-2′-deoxyadenosine ( dA) is one of several promutagenic DNA modifications arising from cellular oxidative metabolism. It is believed that these background DNA lesions may contribute to various diseases, such as cancer. Therefore, human biomonitoring of dA in urine could be a potential marker for oxidative stress-related DNA damage. Existing methods for quantifying urinary dA use 32P postlabeling. We have developed a nonradioactive, fast, and easier method based on column-switching liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry (LC/APCI-MS/MS) in the positive mode. Differences in column temperatures were used to influence analyte retention and sample focusing. With multiple reaction monitoring (MRM) mode the afforded limit of detection was about 0.7 pM when starting with 3 ml of urine. The urinary excretion rates of dA from 28 nonsmoking and 5 smoking men were 10.0–99.6 pmol/24 h, and did not correlate with body weight, age, or plasma vitamin C concentration. The 5 smokers excreted 30.5 ±8.5 and the 28 nonsmokers excreted 38.6 ± 2.4 pmol dA per 24 h, p=.37 (mean ± SEM). The demonstrated level of performance suggests the future applicability of this method to studies of cancer and other diseases related to oxidative stress in humans.